MaxCyte (NASDAQ:MXCT – Get Rating) and SomaLogic (NASDAQ:SLGC – Get Rating) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their analyst recommendations, profitability, institutional ownership, risk, dividends, valuation and earnings. Insider and Institutional Ownership 65.9% of MaxCyte shares are held by […]
MaxCyte (NASDAQ:MXCT – Get Rating) and SomaLogic (NASDAQ:SLGC – Get Rating) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their earnings, valuation, institutional ownership, risk, profitability, dividends and analyst recommendations. Institutional & Insider Ownership 65.9% of MaxCyte shares are held by […]
SomaLogic (NASDAQ:SLGC – Get Rating) and Inotiv (NASDAQ:NOTV – Get Rating) are both small-cap business services companies, but which is the superior investment? We will contrast the two companies based on the strength of their valuation, profitability, earnings, risk, analyst recommendations, institutional ownership and dividends. Institutional and Insider Ownership 58.7% of SomaLogic shares are owned […]
Wall Street brokerages expect SomaLogic, Inc. (NASDAQ:SLGC – Get Rating) to post earnings of ($0.16) per share for the current quarter, according to Zacks Investment Research. Two analysts have provided estimates for SomaLogic’s earnings, with the lowest EPS estimate coming in at ($0.19) and the highest estimate coming in at ($0.13). The company is expected […]
Brokerages expect SomaLogic, Inc. (NASDAQ:SLGC – Get Rating) to announce $23.30 million in sales for the current fiscal quarter, Zacks Investment Research reports. Two analysts have made estimates for SomaLogic’s earnings. The lowest sales estimate is $23.00 million and the highest is $23.60 million. The business is scheduled to issue its next earnings results on […]